201. Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: A report from the e-SELECT registry
- Author
-
Cuculi, F, Banning, AP, Abizaid, A, Bartorelli, AL, Baux, AC, Džavík, V, Ellis, S, Gao, R, Holmes, D, Jeong, MH, Legrand, V, Neumann, FJ, Nyakern, M, Spaulding, C, Stoll, HP, Worthley, S, Urban, P, Chieffo, A, Naber, C, Jensen, LO, Sano, K, Srinivas, V., BARBATO, EMANUELE, Cuculi, F, Banning, Ap, Abizaid, A, Bartorelli, Al, Baux, Ac, Džavík, V, Ellis, S, Gao, R, Holmes, D, Jeong, Mh, Legrand, V, Neumann, Fj, Nyakern, M, Spaulding, C, Stoll, Hp, Worthley, S, Urban, P, Barbato, Emanuele, Chieffo, A, Naber, C, Jensen, Lo, Sano, K, and Srinivas, V.
- Subjects
Registrie ,Male ,medicine.medical_treatment ,Coronary ,Infarction ,Coronary Disease ,heart disease ,postoperative period ,Coronary artery disease ,coronary stent ,Antibiotics ,Sirolimu ,Myocardial infarction ,Registries ,Angioplasty, Balloon, Coronary ,Coronary Vessel ,register ,Antibiotics, Antineoplastic ,diabetes mellitu ,adult ,article ,Drug-Eluting Stents ,Middle Aged ,Antineoplastic ,Coronary Vessels ,surgical procedures, operative ,female ,Treatment Outcome ,Drug-eluting stent ,diabetes mellitus ,Cardiology ,Complex lesion ,disease registry ,treatment outcome, Aged ,Cardiology and Cardiovascular Medicine ,drug eluting stent ,medicine.medical_specialty ,heart infarction ,prevalence ,coronary artery dilatation ,Internal medicine ,Angioplasty ,heart muscle revascularization ,medicine ,rapamycin, adult ,Humans ,controlled study ,cardiovascular diseases ,human ,outcome assessment ,Aged ,Sirolimus ,Sirolimus-eluting stent ,business.industry ,rapamycin ,percutaneous coronary intervention ,Percutaneous coronary intervention ,medicine.disease ,major clinical study ,mortality ,Surgery ,Complex lesions ,major adverse cardiac event ,Conventional PCI ,business ,coronary artery disease ,male ,treatment outcome ,Balloon ,Female ,Mace - Abstract
Aims: Performing percutaneous coronary intervention (PCI) to multiple coronary lesions during the same procedure has potential economic and social advantages. However comprehensive outcome data of real world practice in a large population is limited. We aimed to compare short- and long-term outcomes between patients with multi-vessel coronary artery disease who either underwent single- or multivessel PCI within the e-SELECT registry. Methods and results: The e-SELECT registry combines data collected at 320 medical centres in 56 countries where patients received CYPHER Select® or CYPHER Select® Plus sirolimus-eluting stent (SES). Rates of myocardial infarction and major adverse cardiac event (MACE) (defined as any death, myocardial infarction or target lesion revascularisation) were compared between patients undergoing single-vessel versus multivessel PCI. A total of 15,147 patients who satisfied the inclusion criteria were included in the e-SELECT registry. Two thousand two hundred and seventy-eight (2,278) subjects (15%) underwent multivessel PCI and 12,869 (85%) had single-vessel PCI. The mean age was higher in the multivessel PCI group (63 vs. 62 years, p
- Published
- 2011